نتایج جستجو برای: oseltamivir

تعداد نتایج: 2005  

Journal: :Journal of virology 2011
Maki Kiso Makoto Ozawa Mai Thi Quynh Le Hirotaka Imai Kei Takahashi Satoshi Kakugawa Takeshi Noda Taisuke Horimoto Yoshihiro Kawaoka

Like the histidine-to-tyrosine substitution at position 274 in neuraminidase (NA H274Y), an asparagine-to-serine mutation at position 294 in this protein (NA N294S) confers oseltamivir resistance to highly pathogenic H5N1 influenza A viruses. However, unlike viruses with the NA H274Y mutation, the properties of viruses possessing NA N294S are not well understood. Here, we assessed the effect of...

2012
Paula E. Miller Aksharananda Rambachan Roderick J. Hubbard Jiabai Li Alison E. Meyer Peter Stephens Anthony W. Mounts Melissa A. Rolfes Charles R. Penn

BACKGROUND The influenza A (H1N1) pandemic swept across the globe from April 2009 to August 2010 affecting millions. Many WHO Member States relied on antiviral drugs, specifically neuraminidase inhibitors (NAIs) oseltamivir and zanamivir, to treat influenza patients in critical condition. Such drugs have been found to be effective in reducing severity and duration of influenza illness, and like...

Journal: :Antiviral therapy 2010
Michèle Ottmann Maude Bouscambert Duchamp Jean-Sébastien Casalegno Emilie Frobert Vincent Moulès Olivier Ferraris Martine Valette Vanessa Escuret Bruno Lina

BACKGROUND With the recent emergence of the novel A(H1N1) virus in 2009, the efficacy of available drugs, such as neuraminidase (NA) inhibitors, is of great concern for good patient care. Influenza viruses are known to be able to acquire resistance. In 2007, A(H1N1) viruses related to A/Brisbane/59/2007 (H1N1) (A[H1N1] Brisbane-like virus), which are naturally resistant to oseltamivir, emerged....

2011
Silvio A. Ñamendys‐Silva Carolina Pérez‐Jiménez Patricia Cornejo‐Juárez Diana Vilar‐Compte Patricia Volkow

OBJECTIVE To describe the clinical course of a confirmed influenza A Pandemic (H1N1) 2009 virus infection in a patient with lymphoblastic lymphoma on chemotherapy. DESIGN Case report. SETTING Instituto Nacional de Cancerología located in Mexico City, a national referral center for cancer patients. PATIENT AND RESULTS A 15-year-old boy, with lymphoblastic lymphoma on chemotherapy. Oseltami...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Takuo Ogihara Takashi Kano Tamae Wagatsuma Sho Wada Hikaru Yabuuchi Shigeki Enomoto Kaori Morimoto Yoshiyuki Shirasaka Shoko Kobayashi Ikumi Tamai

Oseltamivir, an ester-type prodrug of the neuraminidase inhibitor [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), has been developed for the treatment of A and B strains of the influenza virus but has neuropsychiatric and other side effects. In this study, we characterized the transport across intestinal epithelial cells and the absorption o...

2014
Yu Liu Yuhong Huang Baolin Wei Xinqiao Liu Yaqing Zhang Xiaomin Huang Yuping Tan Zengtao Sun

Objective. To evaluate the efficacy and safety of CHDI in the treatment of influenza infection. Method. A randomized double-blind, double dummy trial was conducted. Influenza patients with a positive influenza A rapid test diagnosis were randomized to receive CHDI or oseltamivir. Primary outcome was assessed by the median fever alleviation time and clearance time, and secondary outcome was tota...

Journal: :Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2003
Katsunori Yamaura Masayoshi Yoshihara

In the epidemic of influenza in fiscal 2002, there was a shortage in Japan of the anti-influenza virus medicine "oseltamivir". For this reason, many medical institutions were forced to shorten the treatment period with this medication. In this study, we compared the shorter oseltamivir treatment and the indicated 5-day course of treatment with the index for the reconsultation rate and medicatio...

2017
Mei-feng Li Xiao-li Li Kai-liang Fan Ying-yi Yu Jing Gong Shu-ying Geng Ya-feng Liang Ling Huang Ji-hua Qiu Xing-han Tian Wen-ting Wang Xiao-lu Zhang Qing-xia Yu Yuan-feng Zhang Peng Lin Li-na Wang Xin Li Ming Hou Lu-yi Liu Jun Peng

BACKGROUND Studies in murine models suggested that platelet desialylation was an important mechanism of thrombocytopenia during sepsis. METHODS First, we performed a prospective, multicenter, observational study that enrolled septic patients with or without thrombocytopenia to determine the association between platelet desialylation and thrombocytopenia in patients with sepsis, severe sepsis,...

Journal: :The Journal of infectious diseases 2005
Hui-Ling Yen Arnold S Monto Robert G Webster Elena A Govorkova

BACKGROUND Control of highly pathogenic avian H5N1 influenza viruses is a major public-health concern. Antiviral drugs could be the only option early in the pandemic.METHODS. BALB/c mice were given oseltamivir (0.1, 1, or 10 mg/kg/day) twice daily by oral gavage; the first dose was given 4 h before inoculation with H5N1 A/Vietnam/1203/04 (VN1203/04) virus. Five- and 8-day regimens were evaluate...

2015
Kotaro Mori Kensaku Murano Ryosuke L. Ohniwa Atsushi Kawaguchi Kyosuke Nagata

The population of influenza virus consists of a huge variety of variants, called quasispecies, due to error-prone replication. Previously, we reported that progeny virions of influenza virus become infected to adjacent cells via cell-to-cell transmission pathway in the presence of oseltamivir. During cell-to-cell transmission, viruses become infected to adjacent cells at high multiplicity since...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید